Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
I first unveiled this "baby biotech" to my Private Briefing subscribers in our very first publication.
And it's been a huge winner for them since then.
Your "win" was extended by a big day last Wednesday when bullish news about a drug this company is working on with partner Gilead Sciences Inc. (NASDAQ: GILD) shot our stock up 16.5%.
In short, the stock I'm showing you today is a proverbial "10-Bagger" – the Holy Grail of stock picking. Heck, it almost became a "13-Bagger."
This is actually the third "10-Bagger" we've brought you in the seven years we've been blessed to be your market guide.
So let's take a look…
About the Author
Before he moved into the investment-research business in 2005, William (Bill) Patalon III spent 22 years as an award-winning financial reporter, columnist, and editor. Today he is the Executive Editor and Senior Research Analyst for Money Morning at Money Map Press. With his latest project, Private Briefing, Bill takes you "behind the scenes" of his established investment news website for a closer look at the action. Members get all the expert analysis and exclusive scoops he can't publish... and some of the most valuable picks that turn up in Bill's closed-door sessions with editors and experts.
Leave a Reply